NO20012047L - Drug delivery system, especially for the delivery of progestins and estrogens - Google Patents

Drug delivery system, especially for the delivery of progestins and estrogens

Info

Publication number
NO20012047L
NO20012047L NO20012047A NO20012047A NO20012047L NO 20012047 L NO20012047 L NO 20012047L NO 20012047 A NO20012047 A NO 20012047A NO 20012047 A NO20012047 A NO 20012047A NO 20012047 L NO20012047 L NO 20012047L
Authority
NO
Norway
Prior art keywords
progestins
estrogens
delivery
delivery system
drug delivery
Prior art date
Application number
NO20012047A
Other languages
Norwegian (no)
Other versions
NO332168B1 (en
NO20012047D0 (en
Inventor
Tommi Markkula
Juha Ala-Sorvari
Harri Jukarainen
Matti Lehtinen
Jarkko Ruohonen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO20012047D0 publication Critical patent/NO20012047D0/en
Publication of NO20012047L publication Critical patent/NO20012047L/en
Publication of NO332168B1 publication Critical patent/NO332168B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
NO20012047A 1998-11-12 2001-04-26 Delivery device, especially for delivery of progestins and estrogens NO332168B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/190,606 US6063395A (en) 1998-11-12 1998-11-12 Drug delivery device especially for the delivery of progestins and estrogens
PCT/FI1999/000887 WO2000028968A1 (en) 1998-11-12 1999-10-26 Drug delivery device, especially for the delivery of progestins and estrogens

Publications (3)

Publication Number Publication Date
NO20012047D0 NO20012047D0 (en) 2001-04-26
NO20012047L true NO20012047L (en) 2001-06-28
NO332168B1 NO332168B1 (en) 2012-07-09

Family

ID=22702031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012047A NO332168B1 (en) 1998-11-12 2001-04-26 Delivery device, especially for delivery of progestins and estrogens

Country Status (30)

Country Link
US (1) US6063395A (en)
EP (1) EP1128811B1 (en)
JP (1) JP2002529493A (en)
KR (1) KR100621426B1 (en)
CN (1) CN1168439C (en)
AR (1) AR021152A1 (en)
AT (1) ATE267004T1 (en)
AU (1) AU760302B2 (en)
BG (1) BG65042B1 (en)
BR (1) BR9915326B1 (en)
CA (1) CA2351068C (en)
CO (1) CO5271704A1 (en)
CZ (1) CZ301609B6 (en)
DE (1) DE69917477T2 (en)
DK (1) DK1128811T3 (en)
EE (1) EE05506B1 (en)
ES (1) ES2221454T3 (en)
HK (1) HK1041814B (en)
HU (1) HU226113B1 (en)
ID (1) ID29190A (en)
IL (2) IL142523A0 (en)
NO (1) NO332168B1 (en)
NZ (1) NZ511216A (en)
PE (1) PE20001041A1 (en)
PL (1) PL194876B1 (en)
PT (1) PT1128811E (en)
RU (1) RU2226387C2 (en)
SK (1) SK286730B6 (en)
WO (1) WO2000028968A1 (en)
ZA (1) ZA200103298B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20060110424A1 (en) * 2000-03-24 2006-05-25 Lyles Mark B Ceramic and metal compositions
EP1272440A2 (en) * 2000-03-24 2003-01-08 Mark B. Lyles High density porous materials
AU2001258442A1 (en) * 2000-05-10 2001-11-20 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
US6299894B1 (en) * 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
ES2253423T3 (en) * 2000-08-23 2006-06-01 Akzo Nobel N.V. FORMULATION OF A TESTOSTERONE ESTER FOR HUMAN USE.
AU2002210580A1 (en) * 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
JP2005503389A (en) * 2001-08-31 2005-02-03 シエーリング オサケユイチア Drug delivery system
WO2003080019A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal reservoir drug delivery devices
JP2006506385A (en) * 2002-10-22 2006-02-23 ザ バイオメリックス コーポレーション Methods and systems for intrathecal delivery of therapeutic agents
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
ES2660627T3 (en) 2003-05-15 2018-03-23 Biomerix Corporation Crosslinked elastomeric matrices, their manufacture and their use in implantable devices
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
AU2005325213B2 (en) 2004-08-04 2010-10-07 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
CN101437571B (en) 2005-10-13 2013-01-02 斯恩蒂斯有限公司 Drug-impregnated encasement
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
PL2062569T3 (en) * 2007-11-22 2011-10-31 Bayer Oy Vaginal delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
ES2718612T3 (en) 2007-12-20 2019-07-03 Evonik Corp Procedure for preparing microparticles that have a low volume of residual solvent
CA3016642A1 (en) * 2008-02-04 2009-08-13 Ferring B.V. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
TWI590843B (en) 2011-12-28 2017-07-11 信迪思有限公司 Films and methods of manufacture
EP2953678B1 (en) 2013-02-06 2020-03-25 Sillender, Mark Therapeutic substance transfer catheter
AU2014214538B2 (en) 2013-02-06 2018-11-15 Mark SILLENDER Embryo transfer catheter and method
CA2916249C (en) 2013-06-21 2021-07-13 DePuy Synthes Products, Inc. Films and methods of manufacture
WO2016180764A1 (en) * 2015-05-13 2016-11-17 Bayer Oy A long acting drug delivery device and its use in contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
WO2019063382A1 (en) * 2017-09-27 2019-04-04 Bayer Oy A method for modifying release of a therapeutically active agent from an elastomeric matrix
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
US20230381197A1 (en) 2022-05-26 2023-11-30 Insigna Inc. Compositions for non-surgical prevention of boar taint and aggressive behavior
WO2023230619A1 (en) * 2022-05-26 2023-11-30 Insigna Inc. Prevention of estrus in sow and ruminants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
CH657779A5 (en) * 1982-10-05 1986-09-30 Sandoz Ag GALENIC COMPOSITIONS CONTAINING CALCITONIN.
EP0230654B1 (en) * 1985-12-28 1992-03-18 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
IT8702928A0 (en) * 1987-07-22 1987-07-22 Alga Di Giudici Angelamaria & FRYER WITH BASKET ROTATING ACCORDING TO A HORIZONTAL AXIS.
DE19975054I2 (en) * 1987-08-08 2000-04-13 Akzo Nobel Nv Contraceptive implant
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
JPH07216233A (en) * 1992-09-21 1995-08-15 Toray Dow Corning Silicone Co Ltd Fluorosilicone rubber composition
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens

Also Published As

Publication number Publication date
NO332168B1 (en) 2012-07-09
RU2226387C2 (en) 2004-04-10
ZA200103298B (en) 2001-10-25
CA2351068A1 (en) 2000-05-25
PL194876B1 (en) 2007-07-31
CN1168439C (en) 2004-09-29
WO2000028968A1 (en) 2000-05-25
IL142523A0 (en) 2002-03-10
CZ20011569A3 (en) 2001-10-17
BG65042B1 (en) 2007-01-31
KR20010075700A (en) 2001-08-09
EP1128811A1 (en) 2001-09-05
ES2221454T3 (en) 2004-12-16
US6063395A (en) 2000-05-16
PT1128811E (en) 2004-09-30
EE05506B1 (en) 2012-02-15
HK1041814B (en) 2005-04-29
HK1041814A1 (en) 2002-07-26
SK286730B6 (en) 2009-04-06
CN1326337A (en) 2001-12-12
JP2002529493A (en) 2002-09-10
EP1128811B1 (en) 2004-05-19
DK1128811T3 (en) 2004-09-27
ID29190A (en) 2001-08-09
HU226113B1 (en) 2008-04-28
ATE267004T1 (en) 2004-06-15
AU1048800A (en) 2000-06-05
SK5132001A3 (en) 2001-11-06
CZ301609B6 (en) 2010-04-28
AR021152A1 (en) 2002-06-12
DE69917477D1 (en) 2004-06-24
CO5271704A1 (en) 2003-04-30
BG105501A (en) 2001-12-29
NO20012047D0 (en) 2001-04-26
KR100621426B1 (en) 2006-09-13
HUP0104037A2 (en) 2002-04-29
IL142523A (en) 2006-06-11
PL348113A1 (en) 2002-05-06
NZ511216A (en) 2002-09-27
BR9915326A (en) 2001-10-09
CA2351068C (en) 2008-09-02
DE69917477T2 (en) 2005-06-02
BR9915326B1 (en) 2013-10-22
AU760302B2 (en) 2003-05-08
PE20001041A1 (en) 2000-10-14
EE200100256A (en) 2002-12-16
HUP0104037A3 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
NO20012047D0 (en) Drug delivery system, especially for the delivery of progestins and estrogens
AU1618800A (en) Microporous drug delivery system
EE200000546A (en) Aerosolized drug delivery system
NO20016277D0 (en) Systems and methods for aerolizing pharmaceutical formulations
BR9801027B1 (en) drug delivery system.
AU5343899A (en) Catheter drug delivery system and method for use
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
MXPA03002070A (en) Contraception process and administration form for the same.
DE69935681D1 (en) Devices for drug administration
GB9520584D0 (en) Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
EP1061987A4 (en) Drug delivery system
DE1015046T1 (en) MICRODISPERSION ADMINISTRATION SYSTEM FOR MEDICINAL PRODUCTS
HK1015789A1 (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use.
ZA200203525B (en) Transdermal contraceptive delivery system and process.
NO20012046L (en) Drug delivery system, especially for delivery of androgens
NO20026212L (en) Compound for drug delivery system and method of preparation of the compound
HUP0203443A3 (en) Novel contraceptive medicament and method for producing the same
AU1685201A (en) Drug inducible system and use thereof
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
ZA200110214B (en) Systems and methods for aerosolizing pharmaceutical formulations.
AUPN924296A0 (en) Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
GB9403187D0 (en) New urea derivatives, processes for the preparation thereof and pharmaceutical compositioncomprising the same
AU5852898A (en) Dosing system for the dosing of liquids, and method and use of the system
HUP0002215A3 (en) Peptide derivatives, process for the manufacture thereof, pharmaceutical compositions comprising thereof and their use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees